drugset / Trial / NCT01052896

Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition

NCT01052896

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness of gabapentin on symptom control in patients with defined functional dyspepsia refractory to conventional proton pump inhibitor therapy and to compare these effects to that of placebo.

Timeline

Start
2010-03
Primary completion
2011-03
Completion
2012-08-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 300 mg Oral

Indications